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                                                 Abstract 
 
Osteoradionecrosis (ORN) of the mandible has been a formidable long term 
complication of radiotherapy, instituted for the treatment of tumors of the head 
and neck region. The un-restorable decayed teeth in the mandible in the path of 
radiation have to be removed, but whether before or after radiation, such 
extractions can still lead to ORN. Its mainstream prophylaxis and treatment is 
Hyperbaric oxygen therapy (HBO), which is expensive and not accessible to all 
the patients.  
 
Therapeutic Ultrasound (US) has been shown to promote repair in bone fractures 
and soft tissue injuries in in vivo studies in rats and humans. In vitro studies have 
shown that long wave US treated osteoblasts, fibroblasts and macrophages 
increased synthesis of growth factors which play prominent roles in angiogenesis 
and healing. The cytokines,  TNF-α (tumor  necrosis  factor  alpha),  receptor  
activator  of  NF-κB Ligand (RANKL)  and  osteoprotegerin (OPG)  have  been  
shown  to  act  directly  or indirectly  on  osteogenic  cells  and  their  precursors  
to  control  differentiation, resorption  and  bone formation. RANKL and TNF-α 
promote osteoclast differentiation and thus bone resorption whereas OPG 
promotes osteoblast differentiation and also competes with RANKL for the 
receptor activator of NF-κB (RANK) receptor present on the osteoclast. Human  
osteoblast cell line (MG63  cells)  were treated with long  wave  (45 KHz , 
intensity-30mW/cm2)  continuous ultrasound (US)    and  incubated for  various 
time periods following  the treatment.  The  reverse  transcriptase  polymerase  
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chain  reaction  (RT-PCR) technique  was  used  for  observing  genetic  
expression  and  real  time  PCR  for quantitative  analysis  of  the  genetic  
expression  of   RANKL  and  OPG  along with  alkaline phosphatase  (ALP),  an  
early  bone  marker  and  osteocalcin  (OCN),  a late  marker.  ELISA  was  
performed  to estimate  the  amount  of  the  cytokine  released  into  the culture  
media,  following  US treatment.  The  osteoblasts  responded  to  US  by  
significantly  upregulating  both  the  OPG  mRNA  and   protein  levels.  There  
was  no  RANKL  mRNA  expression  observed  in both  the US  and  control  
groups  and  the  protein  levels  were  also  very  low  in  both groups  and  
significantly  low  in  the  US  group. There  was  also no  TNF-α  expression  and  
the  TNFα  protein levels  were  insignificant.  ALP and OCN mRNA were 
significantly up regulated in the US group.   
 
To my knowledge this is the first study that shows the effect of US on OPG and 
RANKL. US appears to up regulate OPG and may down regulate RANKL 
production.  From these  findings, we conclude that therapeutic ultrasound may 













1. Osteoradionecrosis (ORN) 
Radiotherapy is an essential treatment modality for oral and head and neck 
malignant neoplasms. Unfortunately it induces alterations in the normal tissues, 
resulting in early and long term complications. Mandibular osteoradionecrosis is 
the most common long term complication of radiotherapy with a variable 
incidence ranging from 2 to 44.2%. With adequate prevention the incidence is 
still around 2-5% (Reher et al.) 
 
Osteoradionecrosis (ORN) of the mandible was for a long time considered as an 
osteomyelitis of the irradiated bone resulting from a triad of radiation, trauma and 
infection. Marx and Klinge redefined this concept and pointed out that 
osteoradionecrosis is not a primary infection of the bone; rather it is induced by a 
metabolic and tissue haemostatic deficiency due to radiation induced cellular 
injury. In 1983, Marx at the University of Miami described a rational foundation 
idea, namely radiation tissue hypoxia, hypovascularity and hypocellularity, tissue 
breakdown and chronic non-healing wounds as the main pathogenesis for ORN. 
Bras et al., have reported that the radiation induced obliteration of the inferior 
alveolar artery is the dominant factor in the onset of osteoradionecrosis leading 
to an ischaemic necrosis of bone. Marx et al., also showed that micro-organisms 




Many definitions have been attributed to ORN over the years but a definition 
given by Hutchinson in 1996 seems to be the most sensible, which states that 
“ORN is an area of exposed bone in the mouth or on the face for more than two 
months in a previously irradiated field in the absence of recurrent tumour”. 
 
1.2 Incidence 
There is a great variance in the incidence rates of ORN in the literature. 
According to the most recent study done by Sulaiman et al, 2003 the incidence of 
ORN was 2% among 187 cancer patients who underwent 951 dental extractions 
with only 7 patients treated with HBO therapy prophylactically. 
 
1.3 Site of Incidence 
The mandible is the most common site of incidence of ORN probably because it 
is often necessary to deliver a high dose of radiation to tumors of the tongue and 
floor of the mouth and also probably as the blood supply is less abundant as 
compared to the maxilla. Furthermore most maxillary tumors are treated 
surgically before or after radiotherapy. 
 
1.4 Classification of ORN 
Coffin in 1983 examined 2853 patients who received radiotherapy for head and 
neck malignancies and suggested that ORN develops in two forms a) Minor and 
b) Major. The Minor form is considered to be a series of small sequestra which 
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separate spontaneously after varying periods of time and can be seen clinically 
but not radiologically. The Major form occurs when necrosis involves the entire 




Many theories have been formulated to explain the etiology of ORN since its first 
observation in 1920s but the most accepted one originates from the work done 
by Marx in 1983.  
 
The Radiation, Trauma and Infection Theory 
In 1970 Meyer named the classical triad of ORN as “radiation, trauma and 
infection”. He described the role of trauma as a portal of entry for the oral 
bacterial flora into the underlying bone. 
 
The theory of non-healing wound due to Hypoxic-Hypovascular-
Hypocellular tissue 
Marx in 1983 examined the traditional concept of the pathophysiology of ORN 
described by Meyer questioning the occurrence of ORN without trauma or 
infection. He studied 26 cases of ORN from which 12 en bloc resection 
specimens were cultured and stained for micro-organisms. The microbiology 
reports showed that all specimens were infected superficially but no organisms 
could be cultutred from the deep, so called infected bone of ORN. The 
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histological findings observed by Marx showed endothelial death, hyalinization 
and thrombosis of vessels with a fibrotic periosteum. Osteoblasts and osteocytes 
were deficient with fibrosis of the marrow spaces. The overall result was a 
composite tissue, which is hypovascular and hypocellular and was proven to be 
hypoxic compared with non-irradiated tissue by direct measurement . 
 
Current Concepts 
Bilal et al, have found in a histological study of human specimens with ORN as 
well as in specimens subjected to just 36 Gy radiation after a few weeks interval, 
a loss of vitality of osteocytes. Marx et al and Rosenberg et al 2003 have 
reported a type of osteonecrosis occurring in patients using bisphosphonates, 
which bears characteristic resemblance to ORN. These osteonecrosis patients 
have undergone suppression of osteoclasia with biphosphonates. 
Bisphosphonates could reduce osteoclastic bone resorption through: (a) inhibition 
of osteoclast recruitment to the bone surface; (b) inhibition of osteoclast activity 
on the bone surface; (c) shortening of the osteoclast life span; and (d) alteration 
of the bone or bone mineral in ways which reduce, by a pure physicochemical 
and not a cellular mechanism, the rate of its dissolution. The first three effects 
could be due to direct action on the osteoclast, or indirectly via the cells which 





1.6 Risk Factors 
• Tumour size and location 
• Radiation dose 
• Local Trauma 
• Dental Extractions 
• Infection 
• Immune defects 
• Malnutrition 
Many patients abuse alcohol and tobacco and are in poor general medical 
condition, which together with poor nutritional status and lack of oral hygiene may 
place them at a higher risk of ORN. 
 
1.7 Time of Development of ORN 
The time of development of ORN following radiation can be variable but the 
majority of cases occur between 4 months and 2 years. Gowgiel in 1960 noted 
that ORN of the mandible develops within 2 years of irradiation. Clayman in 1997 
found that the highest risk for ORN was between 4 and 12 months following 
irradiation. 
 
1.8 Diagnosis of ORN 
The diagnosis of ORN is primarily based on the clinical signs of ulceration of the 
mucous membrane with exposure of necrotic bone. The lesion may be 
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accompanied by symptoms of pain, dysesthesia, fetor oris, dysguesia and food 
impaction in the area (Braumer et al, 1979; Epstein et al, 1987). 
Marx and Johnson (1987) found the following diagnostic signs to correlate with 
increased signs of radiation tissue injuries: 
• Induration of tissue 
• Mucosal radiation telangiectasias 
• Loss of facial hair growth 
• Cutaneous atrophy 
• Cutaneous flaking and keratinization 
• Profound xerostomia 
• Profound taste loss 
 
1.9 Investigation of ORN 
ORN can be investigated by many techniques but the ideal investigative tool 
according to Hutchinson (1996) should be able to offer the following: 
1. Record quantitatively and qualitatively the severity and extent 
2. Monitor the progress of treatment 
3. Predict patients at risk 
4. Predict risk factors more confidently 
5. Permit comparisons of treatment regimens 




The following investigations would be useful: 
1. Radiography, CT and MRI 
2. Nuclear medicine 
3. Ultrasonography 
4. Transcutaneous and transmucosal oximetry 
5. Near Infrared Spectroscopy 
 
1.10 Management of ORN 
The aims of the treatment are elimination of pain and associated infections, 
achieve vascularisation and mucosal/skin coverage, improvement of mouth 
function (opening, speech, mastication) and the elimination of deformity (fistulas, 
bone exposures and pathological fractures). 
 
The various treatment options for osteoradionecrosis are as follows – 
1. Antibiotics and curettage. 
2. Hyperbaric oxygen (HBO) therapy with or without surgery. 
3. Debridement and local flaps. 
4. Resection and reconstruction. 
5. Therapeutic Ultrasound (US) - Most recently described (Harris 1992, Refer et 
al, 1997, 1998, Doan et al., 1999) 
 
Dental management of patients who are about to receive therapeutic radiation 
involving the jaws, remains a perplexing problem. The unrestorable decayed 
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teeth in the mandible which come in the path of radiation have to removed, 
whether before or after radiation and can lead to osteoradionecrosis. 
 
Conservative Management 
According to Scully and Epstein (1996), conservative management with 
medication and local wound care help in resolving 60% of the cases. 
Maintenance of good oral hygiene with the use of 0.02% chlorhexidene mouth 
washes after meals and constant saline washes are a must. Debris should be 
washed/irrigated and sequestra should be allowed to separate spontaneously or 
gently removed, since any surgical interference may encourage extension of the 
necrotic process because of the lack of normal bone repair. Though ORN is not 
primarily an infectious process, tetracyclines have been recommended because 
of their selective uptake by bone (Rankow and Weissman, 1971). Penicillin has 
also been used, because of the involvement of oral bacteria in the superficial 
contamination (Marx et al 1985). Morton and Simpson, 1986 recommend packs 
of BIPP (Bismuth and Iodoform Paraffin paste) for covering small areas of 
exposed bone and delicate granulation tissue for keeping necrotic bone cavities 
clean. 
 
Hyperbaric Oxygen (HBO) therapy 
HBO is administered as 20 sessions of 90 minutes each, breathing 100% 
humidified oxygen at 2.4 atmospheres absolute pressure before surgery and 10 
sessions after surgery. The empirical use of HBO to promote neovascularity and 
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neocellularity in irradiated and other sclerotic bone conditions has had success, 
though usually as an adjunctive preparation to resection and reconstruction. 
 
Marx has confirmed the value of hyperbaric oxygen as an adjunct to promote 
neovascularity and neocellularity but recommends radical excision and 
reconstructive surgery for 70% of the cases. Both the adjunctive HBO therapy 
and surgery are a formidable experience to the patient who has already had 
extensive surgery and other therapies for the malignant neoplasm. The major 
disadvantages of HBO are that it is time consuming and expensive and most of 
the previous studies done to prove its efficacy are uncontrolled.  Also HBO 
therapy is hazardous in patients with chronic emphysematous lung disease 
which is not uncommonly associated with oral cancer.   
 
According to Clayman it costs 1.5 million dollars to treat 100 patients with HBO. 
In Singapore the cost of HBO therapy per person for 30 sessions is 7800 Sing $ 
at the rate of 260 S$ per session (Tan Tok Seng Hospital). A multicentre 
randomized, placebo-controlled, double blind trial done by Annane et al showed 
that the patients treated with HBO not only failed to benefit from the treatment but 
also they had an unfavourable outcome as compared to the patients treated with 
placebo. Similarly Cawood et al have recently shown in 329 patients that HBO 
did not improve the integration outcome of titanium implants in irradiated jaws 
(unpublished). Coulthard et al, in their review on the therapeutic use of HBO for 
irradiated dental implant patients, have clearly mentioned that there is no 
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substantial evidence for the use of HBO and that more randomized controlled 
trials are required to determine its effectiveness. 
 
Ultrasound (US) Therapy 
It is obvious that HBO could not cure many cases of ORN and moreover it is too 
expensive to use it as a prophylactic measure in oral cancer patients receiving 
radiotherapy. The cost of HBO for a single patient is enough for buying at least 5 
US machines which are readily available, economic and easy to apply. US has 
been proven to enhance bone formation, angiogenesis and synthesis of growth 
factors and cytokines which are essential to bone metabolism.  
 
Surgery 
Surgery is very often a treatment option for ORN. Surgical options start with the 
removal of small sequestra and increase depending on the case to 
sequestrectomy, alveolectomy with primary closure, closure of oro-cutaneous 
fistulae and flaps to cover the area. In extreme cases large resections and hemi-
mandibulectomies are performed and the bone should be reconstructed 
preferably with a bone source with its own blood supply, like fibula or iliac crest 
vascularized flaps.  
 
2. Therapeutic Ultrasound 
 
Disturbed bone healing may occur as a side-effect of various therapies like 
osteotomies, bone grafting, distraction osteogenesis and radiation therapy. Over 
the years various interventions have been used to stimulate the healing process 
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and among them ultrasound remains distinguished by being non-invasive and 
easy to apply. Ultrasound has been traditionally used in the field of physiotherapy 
to treat soft tissue disorders by deep heating the tissues using intensities of 0.5 
to 3 watts/cm². The intensities used for bone healing are considerably lower than 
those used in physiotherapy because of the risk of over-heating the bone. 
 
2.1 Historical 
It was in 1880 when Jacques and Pierre Curie first observed that certain crystals 
generated electricity when distorted. This observed effect which was called the 
piezo-electric effect when reversed resulted in the emission of a high frequency 
sound wave which we call the ultrasonic wave or precisely as ultrasound. The 
crystals when subjected to an alternating current, expand and contract resulting 
in the production of ultrasound. Paul Langevin (France, 1926), during the First 
World War, used this effect in the detection of submarines. He was also the first 
to observe the biological effects of ultrasound; fish introduced into a tank with 
strong ultrasound field died after a period of violent motions and investigators 
experienced pain of considerable severity when they thrust their hands into the 
tank.  
 
Pohlman in Germany,1938, was the first to construct an ultrasound device to 
treat patients and found that patients with lower back pain, myalgias and 
neuralgias responded favorably to treatment of the affected areas  for 5 to 10 
minutes daily for 10 days using a frequency of 800 kHz and an intensity of 4 to 5 
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mW/cm².  The first reported successes to ultrasound treatment lead to the 
widespread medical use of ultrasound, however, the influence of ultrasound on 
bone received little attention at first as bone was considered a limitation to the 
use of ultrasound and studies concerning the influence of ultrasound on bone 
focused mainly on bone damage.  
 
In 1950, Maintz published the first study in which the relationship between 
ultrasound and bone healing was investigated. In three month old rabbits, a piece 
of the radius was resected bilaterally and the ultrasound treatment regimen 
involved exposure to different intensities for different time periods. A frequency of 
800 kHz was used. The resected sites were examined histologically and 
radiologically. Exposures to ultrasound at higher intensities showed a reduction 
and arrest of callus formation and detachment of epiphysis. The untreated legs 
healed without complications. Interestingly lower doses did cause osteogenesis 
at a site distant from the resected site and ultrasound application and also the 
simultaneously exposed ulnae showed sub-periosteal osteogenesis. The study 
did not show any accelerated healing of bone. However, similar treatment 
regimens showed positive effects on callus formation in another study which 
involved bilateral femoral fractures in rabbits (De Nunno, 1952). In a controlled 
study in rabbits by Carradi and Cozzolino, 1952 continuous wave 800 kHz 
ultrasound of 1.5 W/cm² was found to stimulate the formation of callus in radial 
fractures.  Strauß in 1948 reported an accelerated healing of chronic 
osteomyelitis due to gun-shot wounds in human subjects. Two cases of 
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osteoradionecrosis, were reported by Halsscheidt et al, 1949,  in which 
ultrasound treatment led to the covering of the non-healing bone with fresh 
granulation tissue, followed by the formation of a sequester  and healing of the 
defects. Knoch in 1965 successfully treated 31 patients with different types of 
fracture non-unions with ultrasound. 27 recalcitrant non-unions were successfully 
treated by Xavier and Duarte in 1983 using pulsed ultrasound at an intensity of 
30mW/cm². A double blind study done using SAFHS (Sonic Accelerated Fracture 
Healing System) showed that ultrasound reduced the time to union by 38% in 61 
dorsally angulated fractures (Kristiansen et al., 1997). There was no difference in 
the healing rates between treatment and placebo groups during a 75 day course 
of SAFHS treatment in tibial fractures fixed with a locked intramedullary nail 
(Emami et al., 1999). The presence of the intramedullary nail may be the reason 
for failure of ultrasound in this study because metals in the path of the beam 
increase the local temperatures resulting in thermal effects coming into play.  
 
2.2 Physical Characteristics of Ultrasound 
Sound waves are longitudinal waves consisting of areas of compression and 
rarefaction. Particles of a material, when exposed to a sound wave will oscillate 
about a fixed point rather than move with the wave itself. As the energy within the 
sound wave is passed to the material, it will cause oscillation of the particles of 
that material. An increase in the molecular vibration in the tissue can result in 
heat generation, and ultrasound (US) can be used to produce thermal changes in 
the tissues. In addition to thermal changes, the vibration of the tissues appears to 
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have effects which are generally considered to be non thermal in nature. As the 
US wave passes through a material (the tissues), the energy levels within the 
wave will diminish as energy is transferred to the material. The energy absorption 
and attenuation characteristics of US waves have been documented for several 
types of tissue.  
 
2.3 Terminology:  
Frequency - the number of times a particle experiences a complete 
compression/rarefaction cycle in 1 second.  
Wave Length - the distance between two equivalent points on the waveform in 
the particular medium.  
Velocity - the velocity at which the wave (disturbance) travels through the 
medium. In a saline solution, the velocity of US is approximately 1500 metre sec
-1 
compared with approximately 350 metre sec
-1 
in air (sound waves can travel 
more rapidly in a denser medium). The velocity of US in most tissues is thought 
to be similar to that in saline. These three factors are related, but are not 
constant for all types of tissue. Average figures are most commonly used to 
represent the passage of US in the tissues. The mathematical representation of 






2.4 US Waveform  
The US beam is not uniform and changes in its nature with distance from the 
transducer. The US beam nearest the treatment head is called the Near field, the 
Interference field or the Frenzel zone. The behaviour of US in this field is far from 
regular, with areas of significant interference. The US energy in parts of this field 
can be many times greater than the output set on the machine (possibly as much  
  
 
 Figure 1    Shape of the Ultrasound Beam 
[Stewart C Bushong, Radiological Science for Technologists, 8th Edition, 2004] 
 
as 12 to 15 times greater). The size (length) of the near field can be calculated 
using d
2
/4λ where d is the diameter of the transducer crystal and λ, the US wave 
length according to the frequency being used.  
 
As an example, a crystal with a diameter of 25mm operating at 1 MHz will have a 
near field/far field boundary where Boundary = 12.5mm
2
/1.5mm ≈ 10cm thus the 
near field (with greatest interference) extends for approximately 10 cm from the 
treatment head when using a large treatment head and 1 MHz US. When using 
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higher frequency US, the boundary distance is even greater. Beyond this 
boundary lies the Far Field or the Fraunhofer zone. The US beam in this field is 
more uniform and gently divergent. The ‘hot spots’ noted in the near field are not 
significant. For the purposes of therapeutic applications, the far field is effectively 
out of reach.  
 
One quality indicator for US applicators (transducers) is a value attributed to the 
Beam Nonuniformity Ratio (BNR). This gives an indication of this near field 
interference. It describes numerically the ratio of the intensity peaks to the mean 
intensity. For most applicators, the BNR would be approximately 4 - 6 (i.e. that 
the peak intensity will be 4 or 6 times greater than the mean intensity). Because 
of the nature of US, the theoretical best value for the BNR is thought to be 
around 4.0 though some manufacturers claim to have overcome this limit and 
effectively reduced the BNR of their generators to 1.0.  
 
2.5 Ultrasound Transmission through the Tissues  
All materials (tissues) will present impedance to the passage of sound waves. 
The specific impedance of a tissue will be determined by its density and 
elasticity. In order for the maximal transmission of energy from one medium to 
another, the impedance of the two media needs to be the same. Clearly in the 
case of US passing from the generator to the tissues and then through the 
different tissue types, this can not actually be achieved. The greater the 
difference in impedance at a boundary, the greater the reflection that will occur, 
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and therefore, the smaller the amount of energy that will be transferred. The 
difference in impedance is greatest for the steel/air interface which is the first one 
that the US has to overcome in order to reach to body. To minimise this 
difference, a suitable coupling medium has to be utilised. If even a small air gap 
exists between the transducer and the skin the proportion of US which will be 
reflected approaches 99.998% which in effect means that there will be no 
transmission.  
                                  
 
Table.1 Approximate Velocities of Ultrasound through Selected Materials 
 
The coupling media used in this context include water, various oils, creams and 
gels. Ideally, the coupling medium should be fluid so as to fill all available 
spaces, relatively viscous so that it stays in place, have impedance appropriate 
to the media it connects, and should allow transmission of US with minimal 
absorption, attenuation or disturbance. At the present time the gel based media 
appear to be preferable to the oils and creams. Water is a good medium and can 
be used as an alternative but clearly it fails to meet the above criteria in terms of 
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its viscosity. In addition to the reflection that occurs at a boundary due to 
differences in impedance, there will also be some refraction if the wave does not 
strike the boundary surface at 90°. Essentially, the direction of the US beam 
through the second medium will not be the same as its path through the original 
medium - its pathway is angled. The critical angle for US at the skin interface 
appears to be about 15°. If the treatment head is at an angle of 15° or more to 
 
 
        Figure.2 Rarefaction of the Ultrasound Beam 
[Stewart C Bushong, Radiological Science for Technologists, 8th Edition, 2004] 
the plane of the skin surface, the majority of the US beam will travel through the 
dermal tissues (i.e. parallel to the skin surface) rather than penetrate the tissues 
as would be expected.  
 
2.6 Absorption and Attenuation:  
The absorption of US energy follows an exponential pattern - i.e. more energy is 
absorbed in the superficial tissues than in the deep tissues. In order for energy to 
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have an effect it must be absorbed, and at some point this must be considered in 
relation to the US dosages applied to achieve certain effects.  
 
Because the absorption (penetration) is exponential, there is (in theory) no point 
at which all the energy has been absorbed, but there is certainly a point at which 
the US energy levels are not sufficient to produce a therapeutic effect.  As the US 
beam penetrates further into the tissues, a greater proportion of the energy will 
have been absorbed and therefore there is less energy available to achieve 
therapeutic effects. The half value depth is often quoted in relation to US and it 
represents the depth in the tissues at which half the surface energy is available. 
This will be different for each tissue and also for different US frequencies. To 
achieve a particular US intensity at depth, account must be taken of the 
proportion of energy which has been absorbed by the tissues in the more 
superficial layers.  
 
As the penetration (or transmission) of US is not the same in each tissue type, it 
is clear that some tissues are capable of greater absorption of US than others. 
Generally, the tissues with the higher protein content will absorb US to a greater 
extent, thus tissues with high water content and low protein content absorb little 
of the US energy (e.g. blood) whilst those with a lower water content and a 
higher protein content will absorb US far more efficiently. It has been suggested 
that tissues can therefore be ranked according to their tissue absorption.  
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Although cartilage and bone are at the upper end of this scale, the problems 
associated with wave reflection mean that the majority of US energy striking the 
surface of either of these tissues is likely to be reflected. The best absorbing 
tissues in terms of clinical practice are those with high collagen content – 
Ligament, Tendon, Fascia, Joint Capsule, Scar Tissue (Watson 2000, Ter Haar 
99, Nussbaum 1998, Frizzel & Dunn 1982)  
 
The application of therapeutic US to tissues with a low energy absorption 
capacity is less likely to be effective than the application of the energy into a 
more highly absorbing material. Recent evidence of the ineffectiveness of such 
an intervention can be found in Wilkin et al (2004) whilst application in tissue that 
is a better absorber will, as expected, result in a more effective intervention (e.g. 
Leung et al 2004).  
 
2.7 Therapeutic Ultrasound & Tissue Healing  
One of the therapeutic effects for which ultrasound has been used is in relation 
to tissue healing. It is suggested that the application of US to injured tissues will, 
amongst other things, speed the rate of healing & enhance the quality of the 
repair. The therapeutic effects of US are generally divided into:  
• Thermal Effects 




Thermal Effects:  
In thermal mode, it will be most effective in heating the dense collagenous 
tissues and will require a relatively high intensity, preferably in continuous mode 
to achieve this effect. Both Nussbaum (1998) and Ter Haar (1999) have 
provided some useful review material with regards the thermal effects of 
ultrasound. Comparative studies on the thermal effects of ultrasound have been 
reported by several authors (e.g. Draper et al 1993, 1995) with some 
interesting, and potentially useful results. It is too simplistic to assume that with 
a particular treatment application there will either be thermal or non thermal 
effects. It is almost inevitable that both will occur, but it is furthermore 
reasonable to argue that the dominant effect will be influenced by treatment 
parameters, especially the mode of application i.e. pulsed or continuous. Baker 
et al (2001) have argued the scientific basis for this issue coherently.  
 
US can be used to selectively raise the temperature of particular tissues due to 
its mode of action. Among the more effectively heated tissues are periosteum, 
collagenous tissues (ligament, tendon & fascia) & fibrotic muscle (Dyson 1983). 
If the temperature of the damaged tissues is raised to 40-45°C, then a 
hyperaemia will result, the effect of which will be therapeutic. In addition, 
temperatures in this range are also thought to help in initiating the resolution of 
chronic inflammatory states (Dyson & Suckling 1978). Having made these 
comments, most authorities currently attribute a greater importance to the non-
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thermal effects of U/S as a result of several investigative trials in the last 15 
years or so.  
 
Non-Thermal Effects:  
The non-thermal effects of US are now attributed primarily to a combination of 
Cavitation and Acoustic Streaming (te Haar 99, Baker et al 2001, Williams 
1987). There appears to be little by way of convincing evidence to support the 
notion of Micromassage though it does sound rather appealing.  
 
Cavitation in its simplest sense relates to the formation of gas filled voids within 
the tissues & body fluids. There are 2 types of cavitation - Stable & Unstable 
which have very different effects. Stable Cavitation occurs at therapeutic doses 
of US. This is the formation & growth of gas bubbles by accumulation of 
dissolved gas in the medium. They take approximately 1000 cycles to reach 
their maximum size. The cavity acts to enhance the acoustic streaming 
phenomena and as such would appear to be beneficial. Unstable (Transient) 
Cavitation is the formation of bubbles at the low pressure part of the US cycle. 
These bubbles then collapse very quickly releasing a large amount of energy 
which is detrimental to tissue viability. There is no evidence at present to 
suggest that this phenomenon occurs at therapeutic levels if a good technique 
is used.  
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Acoustic Streaming is described as a small scale eddying of fluids near a 
vibrating structure such as cell membranes & the surface of stable cavitation 
gas bubble (Dyson & Suckling 1978). This phenomenon is known to affect 
diffusion rates & membrane permeability. Sodium ion permeability is altered 
resulting in changes in the cell membrane potential. Calcium ion transport is 
modified which in turn leads to an alteration in the enzyme control mechanisms 
of various metabolic processes, especially concerning protein synthesis & 
cellular secretions.  
The result of the combined effects of stable cavitation and acoustic streaming is 
that the cell membrane becomes ‘excited’ i.e, up regulated, thus increasing the 
activity levels of the whole cell. The US energy acts as a trigger for this process, 
but it is the increased cellular activity which is in effect responsible for the 
therapeutic benefits of the modality (Watson 2000, Dinno et al 1989, Leung et al 
2004).  
Micromassage is a mechanical effect which appears to have been attributed 
less importance in recent years. In essence, the sound wave traveling through 
the medium will cause the molecules to vibrate, possibly enhancing tissue fluid 
interchange & affecting tissue mobility.  
 
2.8 Effect of Ultrasound on Tissue Repair 
The application of ultrasound during the inflammatory, proliferative and repair 
phases is of value not because it changes the normal sequence of events, but 
because it has the capacity to stimulate or enhance these normal events and 
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thus increase the efficiency of the repair phases (ter Haar 1999). It would 
appear that if a tissue is repairing in a compromised or inhibited fashion, the 
application of therapeutic ultrasound at an appropriate dose will enhance this 
activity. If the tissue is healing ‘normally’, the application will, it would appear, 
speed the process and thus enable the tissue to reach its endpoint faster than 
would otherwise. 
 
Cellular Effects of Ultrasound 
 
There is an evidence of increased uptake of calcium ions by fibroblasts exposed 
to the therapeutic levels of ultrasound which may be due to the action of shear 
forces on the plasma membrane, produced by acoustic streaming in stable 
cavities. Temporary increase in the intracellular calcium ions could act as a 
signal for changes in the cell activity leading to a cascade of events as a result of 
which wound healing is accelerated (Young et al., 1990)  
For example in fibroblasts, the protein synthesis is stimulated by ultrasound 
therapy, in platelets the release of serotonin and presumably the stimulators of 
wound healing such as platelet derived growth factor (PDGF) is induced, in mast 
cells the release of histamine is stimulated, and in macrophages growth factor 
release is increased. The observed acceleration of wound healing following 
exposure to ultrasound therapy could be due to the collective effects of these 
cellular events (Doan et al., 1999). 
Ultrasound stimulates bone formation 
 
It was shown by Doan et al in 1999 that therapeutic ultrasound induces in-vitro 
cell proliferation, collagen/non-collagenous protein production, bone formation 
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and angiogenesis. Therapeutic angiogenesis can be used to reduce unfavorable 
tissue effects caused by local hypoxia, including osteoradionecrosis and to 
enhance tissue repair. Though US enhances bone formation it is not completely 
understood as to how it acts at the molecular level. 
 
2.9 Ultrasound Apparatus 
The ultrasound apparatus consists of two parts, a generator and a ceramic 
transducer mounted in the treatment applicator. The transducer converts the high  
 
                         
Fig.3 The Long Wave Ultrasound Machine; produces intensities from 5 to 50 




frequency alternating current from the generator into the ultrasound pressure 
waves. The ultrasound machine is calibrated in two criteria – frequency and 
intensity. Frequency is measured in mega Hertz (Mhz) where 1 hz is equal to 1 
cycle per second. The intensity of the wave energy is measured in Watts per 
centimeter square (W/cm2). Recently a new device has been developed that, 
instead of using the traditional frequencies of 1 to 3 MHz, uses “long wave” 
ultrasound at 45 KHz. This wave penetrates the tissues, reaching areas as deep 
as several centimeters, instead of millimeters as with the megahertz machines. 
To minimize heating effects it uses low intensities (5 to 50 mW/cm2). 
 
The Ultrasound Transducer 
A transducer converts one form of energy to another. The ultrasound transducers  
 
 
                                 Figure.4 Ultrasound Transducer  
 41 
convert electrical energy to ultrasonic energy. The crystal is the active portion of 
the transducer. The backing block is used to dampen the oscillations to form 
finite pulses and establish pulse length.  
 
Piezoelectric Crystals 
These are materials which change in physical dimension when an electric field is 
applied. Most commonly used material for these crystals is Lead Zirconate  
 
 
Figure.5 An Electric Field re-aligns the dipoles in a Piezo-electric crystal. 
 A – unaligned crystal, B – Crystal aligned by electricity. 




Titanate(PZT). Quartz is a naturally occurring piezoelectric material studied by 
the Curies and used commonly in therapeutic ultrasound transducers. The 
thickness of the crystal determines the resonant frequency. Transducers are 
generally designed to operate at a frequency corresponding to twice the 
thickness of the crystal. 
 




3.1 Bone remodelling 
 
Bone remodeling is a continuous, life long process of bone resorption and bone 
formation that renews the skeleton while maintaining its structure. It is a complex 
phenomenon which results from the activities of osteogenic cells like osteoblasts 
and osteocytes and the osteolytic osteoclasts. Osteoblasts make bone whereas 
osteoclasts resorb (Teitelbaum et al., 1997), but the two processes are 
inseparable.  
 
Osteoclasts are differentiated cells whose path of development from 
monocyte/macrophage precursors to multinucleated cells includes various stages 
like proliferation, differentiation, fusion and activation. These events are under 
the influence of hormones and cytokines like interleukins, tumor necrosis factor 
alpha (TNF-α), transforming growth factor beta (TGF-β) and prostaglandin E2 
which act in concert (Teitelbaum et al.,2000). The recently discovered receptor 
activator of NF-қβ ligand (RANKL), an essential cytokine for osteoclastogenesis, 
has led to a better understanding of osteoclast cell biology and has provided 
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important insights into the pathogenesis of human metabolic bone diseases 
(Lacey et al, 1998). 
 
Osteoblasts are bone forming cells derived from bone marrow and are 
transformed into osteocytes over a period of time when they get trapped in 
mineralized bone.  Osteoblasts and osteoclasts are closely related in time and 
space. After receiving a stimulus (mechanical load, growth factors, hormones) 
osteoclastic cells appear on the bone surface and resorb the mineral 
components of bone (Blair et al., 1998). Osteoblasts when stimulated by 
osteoclastic contacts and/or osteoclastic soluble factors, deposit osteoid 
substance at the resorption site, thereby initiating new bone formation. 





The development of osteoclasts is controlled by osteoclastogenic factors 
synthesized by osteoblasts, like RANKL, OPG and TNF-α. RANKL (also known 
as TRANCE / OPGL / ODF) which is expressed on the surface of stromal bone 
marrow cells and osteoblasts, plays a central role in osteoclastogenesis by 
providing an essential signal to OC progenitors through the membrane-anchored 
receptor, RANK (Hofbauer et al., 2000). Signal transduction through RANK (Hsu 
et al., 1999, Hofbauer et al., 2000) leads to OC differentiation and functional 
activation (Yasuda et al., 1998,1999). This signaling pathway can be disrupted by 
a naturally occurring decoy receptor for RANKL, termed osteoprotegerin (OPG), 
 44 
which blocks the interaction between RANKL and RANK (Yasuda et al., 1998). 
Bone formation in principle can be assessed by the relative ratio of OPG to 
RANKL. TNF-α is one of the most potent osteoclastogenic cytokines produced in 
inflammation (Kwan Tat S et al., 2004, Warden et al., 2001). TNF-α is 
responsible for stimulating osteoclastic resorption both in vitro (Reher et al., 
2002) and in vivo (Warden et al., 2001).  TNF-α exerts its osteoclastogenic effect 
by activating NF-κB through an intracellular mechanism overlapping that of 
RANKL (Lacey et al., 1999). TNF-α potently activates osteoclasts, through a 
direct action independent of RANKL but strongly synergistic with RANKL (Lacey 
et al., 1999). TNF-α and RANKL, whether acting individually or in combination, 
exert a real impact on osteoclast differentiation (Naruse et al., 2000). 
 
3.2 RANKL (receptor activator of NF-қB ligand) 
RANKL is a protein with 317 amino-acids. It belongs to the TNF super-family and 
is largely expressed in bone, bone marrow and lymphoid tissue. The 
predominant role of this cytokine in bone physiology is the stimulation of 
osteoclastic differentiation/activation and the inhibition of osteoclast apoptosis 
(Khosla et al., 2001). RANKL in association with macrophage-colony stimulating 
factor (M-CSF) is necessary and sufficient for the complete differentiation of 
osteoclastic precursors into mature osteoclasts. RANKL knock-out mice present 
a severe a severe osteopetrosis and a total loss of osteoclasts (Yasuda et al., 
1998). RANKL exists both in soluble and membranous forms (Ikeda et al., 2001). 
The soluble form, which corresponds to the c-terminal part of the membranous 
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RANKL, may be produced either directly by the cell through an alternative 
splicing followed by an excretion in the extra-cellular medium or by a protelytic 
cleavage of membranous RANKL. Different proteases have been proposed to 
carry out this cleavage, like, tumor necrosis factor converting enzyme (TACE), 
the membranous metalloprotease MT1-MMP and recently the A disintegrin and 
metalloprotease 19 (Armstrong et al., 2002). The ectodomain structure of the 
protein RANKL is made up of a homotrimer.  The structural form of RANKL, 
necessary for the interaction between RANKL and its specific receptor RANK, 
binds to three RANK molecules (Lam et al., 2001).  
 
The protein kinase C (PKC) pathway plays an important role in the regulation of 
RANKL mRNA expression in osteoblasts. The protein kinase A (PKA) pathway 
may also have an important involvement since the effects of parathyroid 
hormone (PTH) on RANKL mRNA expression in murine bone marrow cultures 
depends on the PKA pathway (Lee et al., 2002). It has been proposed that 
RANKL would act through phospholipase C to release Ca(2+) from intracellular 
stores, thereby accelerating the nuclear translocation of NF-қβ and promoting 
osteoclast survival (Komarova et al., 2003). 
 
3.3 RANK (receptor activator of NF-қB ligand) 
RANK is a transmembrane protein of 616 amino-acids. It belongs to the TNF 
superfamily and is expressed primarily on cells of the monocyte/macrophage 
lineage including osteoclast precursors, B and T cells, dendritic cells and 
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fibroblasts (Khosla et al., 2001). It is also present on the surface of matur 
osteoclasts. Like other TNFR-related proteins, RANK is known to activate a 




 Figure.6 Current understanding of preosteoblastic/stromal cell regulation of 
osteoclastogenesis (S.Khosla, 2001)  
 
associated factor proteins (TRAF), activation of transcription factors (NF-қβ, AP-1 
and NFAT2), activation of mitogen activated protein kinases cascades (MAPK-
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like, ERK, JNK  and p38) and induction of Src- and phosphatidylinositol 3-kinase-
dependent Akt activation (Lee et al., 2003). 
 
3.4 OPG (osteoprotegerin) 
OPG, which is synthesized as a protein of 401 amino-acids, is cleaved to give a 
380 amino-acids mature protein (Khosla et al., 2001). It is released in its soluble 
form by stromal cells/osteoblasts after losing its transmembrane and cytoplasmic  
domains. Thus OPG differs from other TNFR superfamily members which remain 
mainly membrane associated (Tan et al., 1997). In contrast to RANKL, OPG 
knock-out mice are osteoporotic (Mizumo et al., 2002). OPG acts as a decoy 
receptor for RANKL and down-regulates the RANKL signaling through RANK. It 
represents an antagonist endogenous receptor that neutralizes the biological 
effects of all forms of RANKL and thus acts as an inhibitor for resorption. It has 
also been reported that OPG can directly inhibit osteoclast activity, independently  
of RANKL, through interactions with still uncharacterized receptors present on 
osteoclasts (Hakeda et al., 1998). The biological effects of OPG on bone cells 
include inhibition of terminal stages of osteoclast differentiation, suppression of 
mature osteoclast activation and induction of apoptosis. 
 
Bone remodeling appears to be mainly controlled by the OPG/RANKL balance in 
the bone micro-environment. Any imbalance in the RANKL to OPG ratio can lead 
to an excessive bone resorption or in contrast an excessive bone formation.  
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3.5 TNF-α 
TNF-α, a multifunctional cytokine is produced by activated macrophages. The 
soluble TNF-α (mature protein) is released, under physiological conditions, by a 
proteolytic cleavage of the precursor proTNF-α, a type II transmembrane protein, 
at the Ala76-Val77 bond. TACE is the protease responsible for this cleavage. 
TNF-α is one of the most potent osteoclastogenic cytokines produced in 
inflammation. TNF-α mediates RANKL stimulation of osteoclast differentiation 
through an autocrine mechanism (Zou et al., 2001). It has been shown that TNF-
α causes bone loss in periodontitis, orthopaedic implant loosening and other 
forms of chronic inflammatory osteolysis (Bingham et al., 2002). TNF-α is 
associated with various cell signaling systems via two types of cell surface 
receptors, namely TNFR I and TNFR II. Both receptors are expressed on a wide 
variety of cell types including bone marrow hematopoietic cells (Sato et al., 
1997). TNFR I is known to mediate most of the biological properties of TNFα 
such as programmed cell death and activation of NF-қβ. In contrast TNFR II 
lacks a death domain, therefore TNFR II is involved in an antiapoptotic effect of 











1. Therapeutic ultrasound does not enhance bone remodeling by  enhancing 
OPG/RANKL ratio in vitro 
 
2. Therapeutic ultrasound does not affect transcription and translation of TNF 
alpha in vitro 
 
3. Therapeutic ultrasound does not affect the transcription of bone markers 





1. Therapeutic ultrasound enhances bone remodelling by  enhancing 
OPG/RANKL ratio in vitro 
 
2. Therapeutic ultrasound does affect transcription and translation of TNF 
alpha in vitro 
 






To find out whether ultrasound enhances bone remodeling in vitro by 
 
1.  enhancing the transcriptional and translational levels of OPG  
 
2. decreasing the transcriptional and translational levels of RANKL 
 












MATERIALS AND METHODS 
 
 
1. Cell culture 
MG63 cell line 
MG63 (ATCC® Number: CRL-1427 ™) which is a human osteosarcoma cell line 
characterized for its osteoblast like properties (Takeuchi et al 1995) was used in 
this study.  In vitro studies of osteoblast behavior use either primary osteoblasts 
or osteogenic osteosarcoma cell lines. Osteosarcoma cell lines have a high turn- 
over rate while retaining the basal characteristics of primary osteoblasts. They 
can help us in understanding the osteoblast function because they represent 
clonal populations derived from specific stages of the osteopath lineage. Clover 
et al in 1994 showed that MG63 cells were suitable models for studying integrin 
sub-unit expression, cell adhesion and for investigating the regulation and 
expression of osteocalcin. They also found that proliferation and alkaline 
phosphatase activity exhibited by MG63 were not representative of primary bone 
cell cultures.  
 
Bu et al in 2003 studied the expression of TNFs and signaling and non-signaling 
TNF receptors in human osteoblasts derived from mesenchymal stem cells and 
well characterized osteosarcoma, MG63 with unamplified gene screening. They 
found a remarkable similarity in mRNA expression between MG63 and non-
transformed osteoblasts. They suggested that in the un-stimulated state, the 
 51 
overall expression of TNF related proteins (OPG, RANKL, TNFα etc) in primary 
osteoblasts overlaps extensively with that in a transformed cell line like MG63. 
 
All cell culture procedures were performed in a sterile air-flow chamber. Cells 
were cultured in 75 sqcm tissue culture flasks (Sarstaed) in Dulbecco’s minimum 
essential medium (DMEM, Gibco BRL) supplemented with 10% heat inactivated 
fetal calf serum (Sigma), 2mmol L-glutamine (Sigma) and 100U/ml each of 
penicillin/streptomycin (Gibco BRL) and incubated at 37ºc. The cells reached 
confluency usually within 3 days and the culture medium was removed from the 
flask and the cell layer was washed using PBS to remove excess culture medium 
and dead cells. The cell layer was then trypsinized using 2 ml of trypsin 
(Invitrogen) in PBS (Gibco RL), excess trypsin removed and the flasks incubated 
at 37ºc for 5 to 10 minutes. Once the cell layer separated 10 ml of culture 
medium was added to each flask to stop the action of trypsin. The cell 
suspension was then collected in 25 ml plastic tubes (Sarstaed) and subjected to 
centrifugation at 1800g for 10 minutes. The supernatant was removed and the 
cells resuspended in 25 ml culture medium. The cells were then counted in a 
Neubar chamber and distributed at 5 x 105 cells/well in six-well culture plates 
(Sarstaed) and incubated for at least 24 hours before being subjected to 
ultrasound treatment.  




2. The Ultrasound Experiment 
Ultrasound treatment was done in a sterile airflow chamber. The 45 kHz long 
wave ultrasound machine used in this study was a Phys-Assist unit supplied by  
 
 
                 Figure.7 US treatment being performed in a sterile air-flow chamber 
 
Orthosonics Ltd (Ashburton, Devon). The six well plates containing the MG63 
cells were suspended in a water bath set to a temperature of 37ºc. The water 
bath was internally lined with rubber in order to absorb the excess ultrasound 
waves and prevent them from reflecting. The ultrasound transducer head was 
fixed to a stand which in turn was fixed to a rotator set to 30-40 revs/minute to 
prevent standing wave formation (standing waves are formed due to reflection of 
ultrasound waves when the transducer head is held stationary and will result in 
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bone resorption in human subjects due to localized concentration of energy). The 
transducer head was immersed in the culture medium present in the well. Each 
well had 5 ml of culture medium which allowed a distance of 5 mm between the 
transducer head and the cells.  
 
An intensity of 30mW/cm² was used for treating the cells. The MG63 cells were 
subjected to ultrasound treatment for 5 minutes as previously described by Doan 
et al 1999. The cells were incubated at 37ºc for 0*, 3, 6, 12, 18 and 24 hour time 
periods after ultrasound treatment (*incase of the 0 hour time point the cultures 
were not incubated at all and the cells were harvested or supernatant collected 
immediately after ultrasound treatment). The controls were sham-sonicated prior                                              
 
 
 Figure.8 Administration of US to each cell culture well of a 6 well-plate.  
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to incubation. The wells were sonicated or sham-sonicated (the transducer was 
applied to the control wells but with the ultrasound machine switched off) in 
triplicates. The culture plates were made to float in a water-bath maintained at 
37ºc. The US transducer-head was immersed in the cell culture supernatant and 
rotated using a rotator/shaker to distribute the US waves equally. The transducer 
head was sterilized with alcohol wipes (Azowipe) and allowed to dry completely 










3. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) RNA 
Extraction 
RNA extraction from the sonicated and control cultures was done immediately at 
the end of the incubation time point using TRIzol reagent (Invitrogen, UK), 
according to the manufacturer’s instructions. The supernatant from the treated 
and control wells was either collected (for ELISA) or discarded and the cells were 
washed with PBS to remove the remaining medium. 500 µl TRIzol was added to 
each well and incubated at room temperature for about 5 to 10 minutes. The cell 
lysate was collected in 1.5 ml Eppendorf tubes (Sarstaed) and transferred to -
70ºc where it could be stored for up to 1 month. 200µl chloroform was added to 
the tubes containing lysate and mixed by inversion of the tubes for 20 seconds 
and incubated at room temperature for 3 minutes. The tubes were then 
centrifuged at 12500g and 4ºc for 15 minutes. This results in phase separation of 
RNA, DNA and protein in the top, middle and bottom layers respectively. The top 
aqueous layer containing RNA was carefully pipetted and transferred to a fresh 
Eppendorf tube to which 1 ml of isopropanol was added and the tubes were 
incubated at -20ºc for at least 10 minutes. Isopropanol helps in precipitating the 
RNA. The tubes were then centrifuged at 12500g for 10 minutes to get a pellet of 
RNA. The supernatant was carefully discarded from the tube and 1 ml of 75% 
ethanol added. The tubes were then centrifuged at 7500g for 10 minutes 
following which the supernatant was discarded and the pellets were allowed to 
air dry. The pellets once dry were suspended in 50 µl of DEPC-water and 
quantified by measuring the absorbance at 260nm and 280nm. A ratio of 1.8 to 
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2.0 between the readings at 260 and 280nm was considered as ideal. At 260 nm, 
an absorbance unit of 1 is equivalent to 40ng/ml of RNA. 
 
DNase Treatment 
All the samples were DNase treated irrespective of the spectrophotometric 
readings. DNase treatment was done using RQ1 DNase (Promega) according to 
the manufacturer’s protocol. The reaction was set up as follows: 
• Up to 8µl RNA 
• 1µl RQ1 DNase 10x reaction buffer 
• 1µg RQ1 RNase-free DNase 
• Nuclease-free water to a 10µl final volume 
The sample was incubated for 30 minutes at 37ºc and 1 µl RQ1 DNase stop 
solution added to terminate the reaction, followed by a 10 minute incubation 
period at 65ºc to inactivate the DNase. Samples were stored at -70ºc until use. 
 
Reverse Transcription (RT) 
It was carried out using SuperScript II RT (Invitrogen) according to the 
manufacturer’s instructions. The cDNA synthesis reaction was set up as follows: 
• 100ng/reaction RNA template 
• 0.1µg oligo (dt)
 
(Promega) 
• 0.5mM dNTP mix 
• Up to 5 µl of double distilled water 
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The reaction mix was incubated at 65ºc for 5 minutes and quick chilled at 4ºc for 
at least 5 minutes. The reaction mixture was then transferred to a tube containing 
the following reagents: 
• 5x reaction buffer 
• o.1M dTT 
• 1 µl RNAse OUT 
The samples were incubated at 42ºc for 2 minutes. After incubation, 1µl of 
SuperScript II Reverse Transcriptase was added to make a final volume of 20 µl 
and the samples were incubated at 42ºc for 50 minutes followed by 70ºc for 15 
minutes. The cDNA thus obtained was stored at -20ºc until use. 
Polymerase Chain Reaction (PCR) 
PCR was carried out on cDNA generated from total RNA. Add the following to a 
PCR reaction tube for a final reaction volume of 25 microlitre:             
• 2.5 µl 10X PCR buffer 
• 1.5 µl 50mM MgCl2 
• 0.5 µl 10 mM dNTP Mix 
• 1 mM amplification primer 1 
• 1 mM amplification primer 2 
• 0.2 µl  Taq DNA polymerase (5U/µl) 
• 1 µl cDNA  
• Up to 25 µl double distilled water 
Amplification was performed in an Eppendorf master cycler gradient PCR 
machine programmed for the following cycles: 
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• 94ºc for 2 minutes – 1cycle 
• 94ºc for 30 seconds, Annealing temperature for 30 seconds, 72ºc for 30 
seconds – 28 to 35 cycles 
• 72º for 7 minutes – 1 cycle 
RT-PCR was performed to assess the expression of OPG, RANKL, TNF-α and 
OCN. The house keeping gene GAPDH was used as the internal control in this 
study. The oligonucleotide primers (Sigma) and the annealing temperatures used 
to amplify the different genes under study are shown in the following table: 
 
Table.2 Primer Sequences and cycle conditions for   RT-PCR 
 
Gene               Accession no.      Sequence                                                       Cycling conditions    Amplicon 
 
 
GAPDH        BC013310.1        F: GAAGTGGAAGGTCGGAGTC                94˚C 1min              313 bp 
                                                  R: GAAGATGGTGATGGGATTTC              57˚C 1min 
                                                                                                                            72˚C 1min 
 29 cycles 
 
OCN              NM_199173       F: GGCCAGGCAGGTGCGAAGC                95˚C 30s                255 bp 
                                                  R: GCCAGGCCAGCAGAGCGACAC          70˚C 30s   
 72˚C 30s 
 35 cycles 
 
OPG              NM002546          F: AGACTTTCCAGCTGCTGA                    94˚C 1min              469 bp 
                                                  R: GGATCTCGCCAATTGTGA                   57˚C 1min 
                                                                                                                           72˚C 1min 
                                                                                                                           29 cycles 
 
RANKL        AF019047           F: CAGGAGACCTAGCTACAGA                 94˚C 40s                381 bp 
                                                  R: CAAGGTCAAGAGCATGGA                   55˚C 40s 
                                                                                                                            72˚C 40s 
                                                                                                                            29 cycles 
 
TNF-α           BC000053           F: GTGGCAGTCTCAAACTGA                    94˚C 40s                332 bp 
                                                  R: TATGGAAAGGGGCACTGA                   55˚C 40s 
                                                                                                                            72˚C 40s 
                                                                                                                            29 cycles 
 






Agarose gel electrophoresis of DNA 
 
Agarose gels were generally made up as 1.5 % multi purpose agarose (Roche, 
Lewes, UK) in TAE buffer (0.04M Tris-acetic acid, 10mM EDTA pH8.0). The 
agarose/TAE solution was heated in a microwave on full power (750 W) for 1 
minute and cooled to about 50ºc. Then 2 µl of a 10 mg/ml solution of ethidium 
bromide was added and the gel solution poured into a gel former and a comb 
inserted. When set the gel was placed into an electrophoresis tank, the comb 
removed and 1x TAE added. Care was taken to cover the surface of the gel with 
the running buffer. Samples to be electrophoresed were mixed with 6x sample 
loading buffer (Promega) and loaded into the wells with a micropipette. The gel 
was electrophoresed 5-10 volts/cm for approximately ½ hour until the dye had 
migrated two thirds of the length of the gel. The PCR products were visualized on 
a UV transilluminator. 
 
4. Quantitative Real Time PCR (QPCR) 
Real Time PCR was performed for RANKL, OPG and ALP.  GAPDH was used 
as the endogenous control. TaqMan real-time quantitative PCR was performed 
using TaqMan PCR chemistry and the ABI 7300 Real Time PCR system (Applied 
Biosystems) according to manufacturer’s instructions. The real-time reactions 
were run using the TaqMan Universal PCR Master Mix (Applied Biosystems) with 
300 nM of each primer and 200 nM of probe, in a total volume of 25 µl. The real-
time PCR program parameters were as follows: 50 °C for 2 min; 95 °C for 
10 min; then 40 cycles of 95 °C for 15 s and 60 °C for 60 s. The concentration of 
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each experimental sample was calculated relative to that of the endogenous 
control (GAPDH) using ABI software.  
 
5. Immunochemistry 
ELISA assays were performed for RANKL (Peprotech, London, UK), TNF-alpha 
(Immunotools, Germany), OPG (R&D Systems Europe Ltd) and OCN 
(NovoCalcin Immunoassay kit, Metra Biosystems). Microtitre plates (NUNC) were 
coated with 100 µl/well of coating antibody at 1µg/ml in PBS (140 mM NaCl, 2.7 
mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, pH 7.2) and incubated overnight at 
4˚C or room temperature according to the manufacturer’s instructions.  The  
plates were  washed  three  times  with  wash  buffer  (0.5-0.05% Tween in PBS, 
pH 7.2 to7.4)  to  remove  unbound  antibody  and  blocked  using  blocking  
buffer  (1% BSA in PBS)  for  1  hour .  The  plates  were  then  washed  and  
incubated  at  room temperature  with  Standards  and  Samples  for  1  hour ,  
followed  by  incubation with  detection  antibody.  The  plates  were  washed  
and  Avidin  peroxidase  HRP  (Dako Ltd, 1:2000)  was  added  to  each  well  
and  the  plates  incubated  for  20 minutes.  The  plates  were then  washed  and  
developed  with 100µl/well  of  colour  reagent  (0.4 mg OPD,  and  0.4 µl  of  
30%  H2O2  in  1  ml  of 0.1M  citric  acid  phosphate  buffer,  pH 5.0).  The  
reaction  was  stopped  within  15  to  30  minutes  with  100  µl  of  1  M  H2SO4  
and  the  absorbance measured  on  an  MRX  II  microplate  reader  (Dynex  
Technologies) at a wave length 450 nm.  
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6. Statistical Analysis 
The statistical difference between the Ultrasound treated and control groups was 
determined using the Student’s T-test for a two-tailed distribution and pooled 
variance on SPSS software. This allowed a comparison of the treated and control 





















1. Effect of Ultrasound on osteoprotegerin (OPG) and receptor activator  
for NF-қB lignand (RANKL) mRNA and protein production 
 
 
Detection of OPG transcription levels by RT-PCR and Q-PCR assays 
The RT-PCR assay showed OPG transcription in both ultrasound treated and 
control groups but the bands seemed to be more prominent in the former. To 
consolidate with those findings the QPCR assay showed an OPG up regulation 
at all time points but more significantly at 0h, 12h, 18h and 24h after incubation 
when compared to the control group.  
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Figure.10 Pictures of gel analysis of RT-PCR products of a) GAPDH, b) OPG. 
US promoted OPG mRNA levels at 0, 6, 18 and 24h prominently while the 
control group showed expression at 12, 18 and 24h time points. The  MG63  cells  
(5x105/well)  were  treated  with 30mW/cm2  intensity  from  a  45 KHz  machine  
for  5 minutes.  The cells were then incubated for six time periods before RNA 







                                                             
Figure.11 US  promoted  OPG  mRNA  levels  of  MG63  significantly  at  0h, 
12h,  18h  and  24h. The  MG63  cells  (5x105/well)  were  treated  with  
30mW/cm2  intensity  from  a  45 KHz  machine  for  5 minutes.  The  cells  were  
then  used  for  assessment  of   mRNA levels at  0h,  3h,  6h,  12h,  18h  and  
24h  after  US treatment. The graphs were plotted with relative expression of 
OPG mRNA with respect to GAPDH, the internal control. (■ ultrasound group, □ 
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OPG protein levels detected by ELISA assay 
OPG protein secretion was observed in both the ultrasound and control groups 
but seemed to be significantly up regulated after 3h and 24h as compared to the 
control. After 0h and 12h the OPG levels seemed to be lower for the ultrasound 






















                                                         
                                                              
Figure.12 US promoted OPG protein levels at 3h and 24h. The  MG63  cells  
(5x105/well)  were  treated with  30mW/cm2   intensity  from  a  45  KHz  machine  
for  5  minutes.  The  supernatant was  then  used  for  the  assessment  of   
protein  levels  at  0h,  3h,  6h,  12h,  18h  and 24h  after  US treatment.  (■ 
ultrasound group, □ control group, *shows significance at p<0.05, ** shows 




Detection of RANKL transcription levels by RT-PCR and Q-PCR assays 
The effect of ultrasound on RANKL transcriptional levels was investigated using 
RT-PCR and Q-PCR. No RANKL expression was observed in untreated MG63 
cells, which is consistent with previous studies.  It was also observed that 
ultrasound did not induce RANKL transcription in MG63 cells (data not shown). 
 
RANKL protein levels detected by ELISA assay 
The secretion of RANKL by MG63 cells as a result of ultrasound treatment was 
detected using ELISA. It was found that the RANKL protein levels were very low 
when compared to OPG. The RANKL levels secreted by ultrasound-treated 


























Figure.13 RANKL protein levels  were  significantly  less  at  6h,  12h,  18h and  
24h time points in the ultrasound treated  group  as  compared  to  the  controls 
which showed no RANKL protein production at all . But in general RANKL levels 
were quite low as compared to OPG protein levels.  The  MG63  cells  
(5x105/well)  were  treated with  30mW/cm2   intensity  from  a  45  KHz  machine  
for  5  minutes.  The  supernatant was  then  used  for  the  assessment  of   
protein  levels  at  0h,  3h,  6h,  12h,  18h  and 24h  after  US treatment.  (■ 
ultrasound group, □ control group, *shows significance at p<0.05, ** shows 












2. Effect of Ultrasound on the mRNA and protein production of TNF-α in  
human osteoblast like cells 
TNF-α transcription was not observed in either the ultrasound or control group 




















Figure 14 - TNF-α levels did not change significantly following ultrasound 
treatment. TNF-α levels were very low as compared to OPG. The  MG63  cells  
(5x105/well)  were  treated with  30mW/cm2   intensity  from  a  45  KHz  machine  
for  5  minutes.  The  supernatant was  then  used  for  the  assessment  of   
protein  levels  at  0h,  3h,  6h,  12h,  18h  and 24h  after  US treatment.  (■ 
ultrasound group, □ control group, *shows significance at p<0.05, ** shows 





3. Effect of Ultrasound on the expression of alkaline phosphatase (ALP) 
and osteocalcin (OCN) in human osteoblast like cells 
 
Differentiated cell function was assessed by the expression of ALP and 
Osteocalcin, markers that are representative of early and late stages of 
osteoblast maturation and bone matrix production respectively (Malaval et al., 
1994). ALP is expressed by pre-osteoblasts and osteoblasts before the 
expression of osteocalcin (Sandberg et al., 1993) whereas osteocalcin binds 
hydroxyapaitte and is produced by osteoblasts just before and during matrix 
mineralization (Salter et al., 2000) 
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Fig.15 – Pictures of gel analysis of RT-PCR products of a) GAPDH, b) OCN. US 
promoted OCN mRNA levels of osteoblasts prominently at all the time points 
while there was no expression observed in the control group at all time points. 
The  MG63  cells  (5x105/well)  were  treated  with 30mW/cm2  intensity  from  a  
transcriptionally up regulated in the ultrasound group when initially analyzed by 
RT PCR assay but as the bands (not shown) were not clearly demarcated Q 
PCR was performed. Q PCR showed that ALP was up regulated by ultrasound at 




Osteocalcin was also up-regulated transcriptionally by ultrasound at all time 
points (fig.15). To complement the mRNA levels OCN protein levels were 
significantly elevated at 3, 6, 12, 18 and 24 time points in US treated cultures as 
compared to controls (fig.16). OCN protein levels in the treatment group 

















Figure.16 US promoted OCN protein levels at 3h, 6h, 12h, 18h and 24h time 
points. MG63  cells  (5x105/well)  were  treated  with  30mW/cm2  intensity  from  
a  45 KHz  machine  for  5 minutes.  The  supernatant from the cultures  was  
then  used  for  assessment  of   protein levels at  0h,  3h,  6h,  12h,  18h  and  
24h  after  US treatment. (■ ultrasound group, □ control group, * shows 
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ALP seemed to be transcriptionally upregulated in the ultrasound group at all 

















                                  
Figure.17 US promoted ALP mRNA levels at 0h,   6h, 18h and 24h time points. 
MG63  cells  (5x105/well)  were  treated  with  30mW/cm2  intensity  from  a  45 
KHz  machine  for  5 minutes.  The  cells  were  then  used  for  assessment  of   
mRNA at  0h,  3h,  6h,  12h,  18h  and  24h  after  US treatment. The graphs 
were plotted with relative expression of ALP mRNA with respect to GAPDH, the 
internal control. (■ ultrasound group, □ control group, * shows significance at 
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Table.3 Summary of Results 
          Ultrasound Treated                    Control Target 
Factor/Marker 
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One of the aims of this study is to explore why US has proved to be empirically 
invaluable for the treatment of conditions like fracture non-unions, 
osteoradionecrosis (ORN) etc. ORN of the mandible is the most common long 
term complication of radiation treatment commonly administered in oral and head 
and neck malignant neoplasms. Dental management of patients who are about to 
receive therapeutic radiation involving the jaws, remains a problem. The non-
restorable decayed teeth in the mandible which come in the path of radiation 
have to be removed, whether before or after radiation and can lead to 
osteoradionecrosis. Marx et al., in 1982 had suggested that hypocellularity, 
hypoxia and hypovascularization resulting in non-healing wound are the 
etiopathogenesis for ORN. There is a sequestration of the cortical bone of the 
mandible eventually leading to pathological fracture if left untreated. Sometimes 
the bone is sequestrated externally. The patient suffers from mucositis, difficulty 
in eating solid food, pain due to sequestration, difficulty in speech and other 
symptoms. The empirical use of HBO to promote neovascularity and 
neocellularity in irradiated and other sclerotic bone conditions has had 
questionable success, though usually as an adjunctive preparation to resection 
and reconstruction. Unfortunately few centers have access to hyperbaric oxygen 
and the treatment is time consuming and not without hazards for the patient. For 
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example, it is impossible to employ HBO therapy in patients with chronic 
emphysematous lung disease which is not uncommonly associated with oral 
cancer. Moreover it is expensive. 
 
Subsequently to this Dyson (1982) introduced the use of ultrasound as a simple 
means of promoting neovascularity and neocellularity in ischemic tissues (Young 
and Dyson 1990). Ultrasound along with other physical modalities of generating 
energy like pulsed high frequency electromagnetic stimulation have been 
employed to facilitate healing in intractable conditions varying from varicose 
ulcers to fracture non-unions. 
 
Therapeutic US was shown by Harris et al, 1992 to be effective in treating 
osteoradionecrosis of the jaw. It has two types of effects on tissues, thermal and 
non-thermal. The thermal effects of US are commonly used in physiotherapy for 
the treatment of acute injuries, strains and pain relief where as the non-thermal 
effects are useful in the stimulation of tissue regeneration, healing of varicose 
ulcers, and protein synthesis in human fibroblasts. It also induces bone formation 
in vitro, by stimulating protein synthesis and cytokine production in human 
osteoblasts, fibroblasts and monocytes. It induces in vitro cell proliferation, 
collagen and non-collagen protein production and angiogenesis. It stimulates 
bone repair and enhances fracture healing in animals. It also enhances fracture 
healing in humans.  Most recently US has been successfully used for enhancing 
healing following distraction osteogenesis in humans. 
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Though the therapeutic value of US in promoting bone formation has already 
been established, the mechanism at the molecular level is not completely 
understood. In this study we investigated the in vitro release of growth factors in 
MG63 (osteoblasts-like cells from an osteosarcoma cell line) following ultrasound 
treatment. The main objective of this study is to explain why US can effectively 
enhance bone healing clinically and to provide evidence which will establish it as 
a conservative and economic mode of treatment for ORN. 
 
Long wave US therapy is mechanical energy administered as acoustical 
pressure waves. Mechanical stimulation has been found to raise the adaptive 
modeling response of the bone micro-environment by the induction of anabolic or 
cytokine molecules. Previous studies have demonstrated that US can raise the 
osteogenic response of OBs through the induction of nitric oxide, prostaglandin 
E2 and growth factors.  
 
Bone remodeling is regulated by the receptor activator of nuclear factor-kappa B 
ligand (RANKL) which is a transmembrane ligand expressed in osteoblasts.  It 
binds to RANK, which is expressed in osteoclast progenitor cells, and induces 
osteoclastogenesis. OPG, a decoy receptor for RANKL, also binds to RANKL, 
and competitive binding of RANKL with RANK or OPG.  The OPG/RANKL/RANK 
cytokine system is essential for bone biology and alterations of this system can 
lead to excess bone resorption or formation. 
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The importance of OPG and RANKL as regulators of osteoclastogenesis is well 
recognised.  Injections of exogenous RANKL induce osteoporosis with increased 
serum calcium levels in mice and targeted ablation of RANKL in mice leads to 
osteopetrosis. The inhibition of osteoclastogenesis by OPG, the decoy receptor 
for RANKL, has also been demonstrated and elevated OPG levels in transgenic 
mice cause increased bone mineral density whereas targeted ablation of OPG 
results in mice developing early onset osteoporosis. The expression of OPG and 
RANKL are developmentally regulated. OPG increases during osteoblast 
differentiation whereas RANKL expression is inversely related to the degree of 
osteoblast differentiation.  TNF-α is a well established resorptive factor which 
induces osteoclast differentiation directly or in synergy with RANKL.   
 
OCN and ALP are markers for bone mineralization in osteoblasts. OCN is a 
highly specific osteoblast marker produced during bone formation and its primary 
structure is highly conserved in vertebrates.  
 
The molecular mechanisms of long wave US on bone remodeling are still not 
completely understood. In the present study we examined the effect of long wave 
US on MG63 cells for the expression and release of the cytokines; OPG, RANKL 
and TNF-α which control bone formation and bone resorption. 
 
2. Discussion of Methodology 
 
MG63 cells which are human osteoblast like cells belonging to a human 
osteosarcoma cell line were used in this study. Cells were cultured in 75 sqcm 
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tissue culture flasks and incubated at 37ºc till they reached confluency. Once 
confluent the cells were passaged and cultured in new flasks. These cells 
reached confluency in 3 days time. The cells were then distributed into 6 well 
culture plates at 5x105 cells per well and incubated for 24 hours before 
ultrasound treatment. The ultrasound experiment was performed in a sterile air-
flow chamber in order to prevent contamination of the cell culture. 
 
The tissue culture flasks were suspended in water contained in a water bath 
maintained at 37ºc and restrained from movement by using a sterile glass rod. 
The water bath was internally lined with rubber to prevent the ultrasound waves 
from reflecting back to the well plates. The ultrasound tranducer head which was 
suspended from a stand was immersed in the culture medium to a point from 
where it was 5 mm from the cells. The stand holding the transducer head was 
placed on a rotator working at 30 rotations per minute to prevent standing wave 
formation in the culture. The transducer head was wiped with alcohol before 
every immersion. 
 
The cells were treated with 30 mW/cm2 intensity for 5 minutes and incubated for 
0, 3, 6, 12, 18 and 24 hour time periods. At the end of these time periods the cell 
culture supernatant was collected for analysis of protein production and the cells 
were used to extract RNA and used in RT-PCR and real Time PCR analysis. We 
wanted to see if ultrasound had an early effect on the transcription and 
translation of OPG, RANKL, TNF-alpha and bone markers, so we chose the first 
 77 
24 hour time period after ultrasound treatment. The cultures were treated with 
ultrasound in triplicates for each time point and the experiment was repeated at 
least twice. Both ELISA and real Time PCR techniques were performed and 
analysed under expert guidance. 
 
This study began by examining the transcriptional expression of the cytokines 
OPG, RANKL and TNF-α and the late bone marker, OCN in MG63 cells following 
ultrasound treatment by RT-PCR assay. The RT-PCR method only allowed us to 
conclude that the cytokines and bone markers were expressed or not expressed. 
The levels of expression could not be estimated.  So QPCR assay was 
performed to quantify the transcriptional levels of the genes of interest. ELISA 
was also performed in order to analyze the amount of cytokine secreted into the 
supernatant from the cell cultures treated with US.  
 
3. Discussion of Results 
QPCR results showed that OPG mRNA production increased immediately (0 hr) 
after ultrasound treatment as compared to control. The mRNA levels at 
subsequent time points of 3, 6, 12 and 18 hrs remained more or less the same 
for the treatment group. Only the 24 hr mRNA levels in the treatment group were 
considerably lower. The control OPG mRNA levels which were very low at time 
0hr rose to a high at 3 hrs and started falling gradually at the subsequent time 
points till 18hrs and rose again at 24 hrs. But the treatment group had 
significantly higher levels of OPG mRNA at 0, 12, 18 and 24 hrs following 
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treatment. Ultrasound appears to have an immediate and nearly sustained effect 
on OPG transcription which dropped only at 24 hrs suggesting that 24 hourly 
treatment with ultrasound could be highly effective. 
 
Both ELISA and QPCR confirmed the up regulation of OPG by MG63 cells during 
the first 24 hours following ultrasound treatment. RANKL transcription was not 
affected by ultrasound and the protein levels were low as compared to OPG but 
significantly low in the ultrasound group. 
 
TNF-α is a potent osteoclastogenic factor but there was no TNF-α expression 
observed in MG63 as a result of ultrasound treatment and the TNF-α protein 
secretion was very low (0.5 – 12pg/ml) and the standard error was high for all 
time points suggesting non-specific binding of the HRP to the elisa plate, due to 
low target protein, leading to a high variability.  Looking at whole protein using 
western blotting or flow cytometric analysis for bound protein might be useful in 
predicting whether ultrasound affects TNF-α. 
  
Both ALP and OCN mRNA were expressed significantly at various time points 
during the 24 hours in the ultrasound group as compared to the controls. OCN 
protein levels were elevated in a similar fashion to the mRNA levels in the US 
treated samples at all time points except the 0 hour; this could be due to the time 
difference between transcription and translation. Elevated levels of OCN and 








Based on the results from the present study we concluded that therapeutic 
ultrasound may enhance bone formation by up-regulating OPG mRNA and 
protein and possibly by preventing RANKL release in osteoblasts. By controlling 
osteoclast differentiation ultrasound affects bone remodeling in favor of bone 
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